U.S. Markets close in 5 hrs 50 mins

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
132.59-0.63 (-0.47%)
As of 10:10AM EDT. Market open.
People also watch
Full screen
Previous Close133.22
Bid133.02 x 100
Ask133.04 x 200
Day's Range132.57 - 133.82
52 Week Range109.32 - 137.08
Avg. Volume5,382,245
Market Cap355.87B
PE Ratio (TTM)22.43
Earnings DateN/A
Dividend & Yield3.36 (2.48%)
Ex-Dividend Date2017-08-25
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals36 minutes ago

    Pharma giants' to clash in court over biosimilar product dispute

    Pfizer Inc. sued Johnson & Johnson Wednesday in the latest twist to the heated and protracted battle over biosimilar competition for a multibillion-dollar blockbuster medicine originally developed by Centocor. The lawsuit further alleges that Johnson & Johnson’s systematic efforts to maintain its monopoly in connection with Remicade — a product it acquired when it bought Malvern-based Centocor for $4.9 billion in 1999 — violate federal antitrust laws and undermines the principal goals of the U.S. Biologics Price Competition and Innovation Act, which became law 2010.

  • 3 Stocks to Help You Make Money in Retirement
    Motley Fool56 minutes ago

    3 Stocks to Help You Make Money in Retirement

    If you want your portfolio to last throughout your retirement, you need to invest in a way to protect your long-term purchasing power as well as your current costs of living. These three companies could very well play a solid role in that part of your portfolio.

  • MarketWatch3 hours ago

    This squabble between two big drugmakers could have major implications for the U.S. health care system

    Pfizer is suing Johnson & Johnson, alleging that it set up contracts to leave Pfizer’s Inflectra out in the cold.